{"id":"https://openalex.org/W2005697115","doi":"https://doi.org/10.3851/imp2527","title":"Review of Drug Interactions with Telaprevir and Antiretrovirals","display_name":"Review of Drug Interactions with Telaprevir and Antiretrovirals","publication_year":2013,"publication_date":"2013-01-23","ids":{"openalex":"https://openalex.org/W2005697115","doi":"https://doi.org/10.3851/imp2527","mag":"2005697115","pmid":"https://pubmed.ncbi.nlm.nih.gov/23344266"},"language":"en","primary_location":{"id":"doi:10.3851/imp2527","doi":"https://doi.org/10.3851/imp2527","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp2527","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP2527","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP2527","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109972406","display_name":"Rolf P. G. van Heeswijk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Rolf PG Van Heeswijk","raw_affiliation_strings":["Janssen Infectious Diseases BVBA, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Infectious Diseases BVBA, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086844845","display_name":"Maria G. Beumont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Maria Beumont","raw_affiliation_strings":["Janssen Infectious Diseases BVBA, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Infectious Diseases BVBA, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011659892","display_name":"Robert S. Kauffman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert S Kauffman","raw_affiliation_strings":["Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066575140","display_name":"Varun Garg","orcid":"https://orcid.org/0000-0002-9310-0005","observed_orcids":["https://orcid.org/0000-0002-9310-0005"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Varun Garg","raw_affiliation_strings":["Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA","institution_ids":["https://openalex.org/I61970326"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109972406"],"corresponding_institution_ids":["https://openalex.org/I137982388"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":1.4559,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":{"value":0.81963928,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"18","issue":"4","first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.04170000180602074,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telaprevir","display_name":"telaprevir","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9620000123977661},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.8209999799728394},{"id":"https://openalex.org/keywords/hiv-hcv-coinfection","display_name":"HIV/HCV coinfection","score":0.8040000200271606},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.722000002861023},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.8659999966621399},{"id":"https://openalex.org/keywords/ns3-4a-protease-inhibitors","display_name":"NS3/4A protease inhibitors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":0.9139999747276306},{"id":"https://openalex.org/keywords/hiv-protease-inhibitors","display_name":"HIV protease inhibitors","score":0.9739999771118164},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.8859999775886536},{"id":"https://openalex.org/keywords/etravirine","display_name":"etravirine","score":0.9350000023841858},{"id":"https://openalex.org/keywords/rilpivirine","display_name":"rilpivirine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9679999947547913},{"id":"https://openalex.org/keywords/pegylated-interferon-and-ribavirin","display_name":"pegylated interferon and ribavirin","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C2778159067","wikidata":"https://www.wikidata.org/wiki/Q408557","display_name":"Telaprevir","level":5,"score":0.8930371999740601},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.8482251167297363},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.8008947968482971},{"id":"https://openalex.org/C2780345285","wikidata":"https://www.wikidata.org/wiki/Q414762","display_name":"Etravirine","level":5,"score":0.7344473600387573},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.6958961486816406},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6670184135437012},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.641082763671875},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.5794217586517334},{"id":"https://openalex.org/C2778986448","wikidata":"https://www.wikidata.org/wiki/Q7517689","display_name":"Simeprevir","level":5,"score":0.5650903582572937},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.5497758984565735},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5333120226860046},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5226683020591736},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.5044742822647095},{"id":"https://openalex.org/C2777182164","wikidata":"https://www.wikidata.org/wiki/Q422585","display_name":"Lopinavir","level":5,"score":0.46233507990837097},{"id":"https://openalex.org/C2778390639","wikidata":"https://www.wikidata.org/wiki/Q2502747","display_name":"Sofosbuvir","level":5,"score":0.4551328718662262},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.4125930368900299},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38253331184387207},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.2602434754371643},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.21796190738677979},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.1958550214767456},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.09946644306182861},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.08308234810829163}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D060085","descriptor_name":"Coinfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3851/imp2527","doi":"https://doi.org/10.3851/imp2527","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp2527","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP2527","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:23344266","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23344266","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3851/imp2527","doi":"https://doi.org/10.3851/imp2527","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp2527","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP2527","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312517","display_name":"Vertex Pharmaceuticals","ror":"https://ror.org/00anb1726"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005697115.pdf","grobid_xml":"https://content.openalex.org/works/W2005697115.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1480425134","https://openalex.org/W1603230621","https://openalex.org/W1991527427","https://openalex.org/W1992668008","https://openalex.org/W1999580368","https://openalex.org/W2009522911","https://openalex.org/W2020004919","https://openalex.org/W2029773175","https://openalex.org/W2036645656","https://openalex.org/W2040200721","https://openalex.org/W2040362309","https://openalex.org/W2062395204","https://openalex.org/W2062563125","https://openalex.org/W2078666841","https://openalex.org/W2081751675","https://openalex.org/W2107512529","https://openalex.org/W2108836992","https://openalex.org/W2111376288","https://openalex.org/W2111549430","https://openalex.org/W2124040992","https://openalex.org/W2124394465","https://openalex.org/W2125963799","https://openalex.org/W2133067107","https://openalex.org/W2133954858","https://openalex.org/W2135432811","https://openalex.org/W2141214317","https://openalex.org/W2142007317","https://openalex.org/W2156165455","https://openalex.org/W2165374230","https://openalex.org/W2183940924","https://openalex.org/W2329815984","https://openalex.org/W2560462942","https://openalex.org/W4241711879"],"related_works":["https://openalex.org/W2321146810","https://openalex.org/W2069221491","https://openalex.org/W4248513538","https://openalex.org/W2001115724","https://openalex.org/W1842010922","https://openalex.org/W7095589904","https://openalex.org/W2146033839","https://openalex.org/W2141202240","https://openalex.org/W2081245176","https://openalex.org/W2052565601"],"abstract_inverted_index":{"HCV":[0,33,59],"infection":[1,36],"is":[2,22],"a":[3,13,79],"major":[4],"cause":[5,15],"of":[6,16,31,54,71,81,91],"mortality":[7,17],"worldwide.":[8],"HCV-related":[9],"deaths":[10],"also":[11],"represent":[12],"leading":[14],"in":[18,37,39,58,64,78,83],"HIV-coinfected":[19],"individuals.":[20],"Telaprevir":[21],"an":[23],"NS3/4A":[24],"protease":[25,99],"inhibitor":[26],"approved":[27],"for":[28],"the":[29,89],"treatment":[30,47],"chronic":[32],"genotype":[34],"1":[35],"adults":[38],"combination":[40],"with":[41,73,94],"pegylated":[42],"interferon":[43],"and":[44,62,104,112],"ribavirin.":[45],"Telaprevir-based":[46],"has":[48],"been":[49],"shown":[50],"to":[51],"increase":[52],"rates":[53],"sustained":[55],"viral":[56],"response":[57],"genotype-1-monoinfected":[60],"patients,":[61],"studies":[63,82,93],"HCV-HIV-coinfected":[65],"patients":[66],"are":[67],"ongoing.":[68],"Drug-drug":[69],"interactions":[70],"telaprevir":[72],"antiretroviral":[74],"drugs":[75],"were":[76],"investigated":[77],"series":[80],"healthy":[84],"subjects.":[85],"This":[86],"review":[87],"summarizes":[88],"results":[90],"interaction":[92],"low-dose":[95],"ritonavir,":[96],"ritonavir-boosted":[97],"HIV":[98],"inhibitors":[100],"(atazanavir,":[101],"darunavir,":[102],"fosamprenavir":[103],"lopinavir),":[105],"efavirenz,":[106],"etravirine,":[107],"rilpivirine,":[108],"tenofovir":[109],"disoproxil":[110],"fumarate":[111],"raltegravir.":[113]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":18},{"year":2013,"cited_by_count":15}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}